The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index.
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243
Cited by
Sorted by citations
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S. K., Bae, J. H., Kwon, H., & Nauck, M. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,061
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 590
Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically assoc…”
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 476
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Oladunni, F. S., Park, J., Pino, P. A., González, O., Akhter, A., Allué‐Guardia, A., Olmo-Fontánez, A. M., Gautam, S., Garcia‐Vilanova, A., Ye, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19891-7 · Cited by 398
Cascade of immune mechanism and consequences of inflammatory disorders
Megha, K. B., Joseph, X., Akhil, V., & Mohanan, P. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153712 · Cited by 374
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 365
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, S. D. S. G., Soares, V. C., Ferreira, A. C., Sacramento, C. Q., Rodrigues, N. F., Temerozo, J. R., Teixeira, L., da Silva, M. A. N., Barreto, E. A., Mattos, M., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009127 · Cited by 336
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Darif, D., Hammi, I., Kihel, A., Saik, I. E. I., Guessous, F., & Akarid, K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104799 · Cited by 340
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection
Margraf, A., Ludwig, N., Zarbock, A., & Rossaint, J. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005175 · Cited by 310
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 302
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 285
Impact of COVID-19 on the thyroid gland: an update
Scappaticcio, L., Pitoia, F., Esposito, K., Piccardo, A., & Trimboli, P. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09615-z · Cited by 285
Ramaswamy, A., Brodsky, N. N., Sumida, T. S., Comi, M., Asashima, H., Hoehn, K. B., Li, N., Liu, Y., Shah, A. S., Ravindra, N. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.003 · Cited by 276
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Rajesh, Y., & Kanneganti, T. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 269
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Forchette, L., Sebastian, W., & Liu, T. (2021) · Current Medical Science · doi:10.1007/s11596-021-2395-1 · Cited by 275
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
Sharma, C., Ganigara, M., Galeotti, C., Burns, J., Berganza, F. M., Hayes, D. A., Singh‐Grewal, D., Bharath, S., Sajjan, S., & Bayry, J. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00709-9 · Cited by 263
Rotondi, M., Coperchini, F., Ricci, G., Denegri, M., Croce, L., Ngnitejeu, S. T., Villani, L., Magri, F., Latrofa, F., & Chiovato, L. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01436-w · Cited by 256
Self-citationCytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J., Asuni, A., Ranganath, T., Grant, P., Subramanian, A. K., Rosenberg‐Hasson, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140289 · Cited by 253
Chemokines and chemokine receptors during COVID-19 infection
Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 248
Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis
Mulchandani, R., Lyngdoh, T., & Kakkar, A. K. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13429 · Cited by 251
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 247
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Hwang, Y., Lu, R., Su, S.-C., Chiang, P.-Y., Ko, S.-H., Ke, F.-Y., Liang, K.-H., Hsieh, T.-Y., & Wu, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-021-00784-w · Cited by 247
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mazza, M. G., Palladini, M., Poletti, S., & Benedetti, F. (2022) · CNS Drugs · doi:10.1007/s40263-022-00931-3 · Cited by 248
Barberis, E., Timo, S., Amede, E., Vanella, V. V., Puricelli, C., Cappellano, G., Raineri, D., Cittone, M. G., Rizzi, E., Pedrinelli, A. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228623 · Cited by 232
Encephalopathy in patients with COVID‐19: A review
Garg, R. K., Paliwal, V. K., & Gupta, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26207 · Cited by 224
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients
Munshi, R., Hussein, M. H., Toraih, E. A., Elshazli, R. M., Jardak, C., Sultana, N., Youssef, M. R., Omar, M., Attia, A. S., Fawzy, M. S., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26360 · Cited by 223
Simadibrata, D. M., Calvin, J., Wijaya, A. D., & Ibrahim, N. A. A. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.01.006 · Cited by 213
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Landstra, C. P., & de Koning, E. J. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.649525 · Cited by 226
Predictors of COVID-19 severity: a systematic review and meta-analysis
Mudatsir, M., Fajar, J. K., Wulandari, L., Soegiarto, G., Ilmawan, M., Purnamasari, Y., Mahdi, B. A., Jayanto, G. D., Suhendra, S., Setianingsih, Y. A., et al. (2020) · F1000Research · doi:10.12688/f1000research.26186.2 · Cited by 211
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Suryawanshi, R. K., Chen, I. P., Ma, T., Syed, A. M., Brazer, N., Saldhi, P., Simoneau, C. R., Ciling, A., Khalid, M. M., Sreekumar, B. K. N., et al. (2022) · Nature · doi:10.1038/s41586-022-04865-0 · Cited by 208
The glycosylation in SARS-CoV-2 and its receptor ACE2
Gong, Y., Qin, S., Dai, L., & Tian, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00809-8 · Cited by 226
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
Barberis, E., Vanella, V. V., Falasca, M., Caneparo, V., Cappellano, G., Raineri, D., Ghirimoldi, M., Giorgis, V. D., Puricelli, C., Vaschetto, R., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.632290 · Cited by 203
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
Noreen, S., Maqbool, I., & Madni, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173854 · Cited by 207
A review of cytokine-based pathophysiology of Long COVID symptoms
Low, R. N., Low, R. J., & Akrami, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1011936 · Cited by 205
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Pyrillou, K., Burzynski, L. C., & Clarke, M. C. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613170 · Cited by 202
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
Pietrobon, A. J., Teixeira, F. M. E., & Sato, M. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579220 · Cited by 187
Vascular alterations among young adults with SARS-CoV-2
Ratchford, S. M., Stickford, J. L., Province, V. M., Stute, N. L., Augenreich, M. A., Koontz, L. K., Bobo, L. K., & Stickford, A. S. L. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00897.2020 · Cited by 180
Kimhofer, T., Lodge, S., Whiley, L., Gray, N., Loo, R. L., Lawler, N. G., Nitschke, P., Bong, S.-H., MORRISON, D. L., Begum, S., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00519 · Cited by 177
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19
Zhang, Z., Zhang, X., Bi, K., He, Y., Yan, W., Yang, C. S., & Zhang, J. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.023 · Cited by 173
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Bhuiyan, F. R., Howlader, S., Raihan, T., & Hasan, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00444 · Cited by 173
Hoagland, D. A., Møller, R., Uhl, S. A., Oishi, K., Frere, J. J., Golynker, I., Horiuchi, S., Panis, M., Blanco-Melo, D., Sachs, D. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.017 · Cited by 177
Cesta, M. C., Zippoli, M., Marsiglia, C., Gavioli, E. M., Mantelli, F., Allegretti, M., & BALK, R. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.808797 · Cited by 173
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
Singh, S. P., Pritam, M., Pandey, B., & Yadav, T. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26254 · Cited by 166
Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review
Burlou-Nagy, C., Bănică, F., Jurca, T., Vicaș, L. G., Marian, E., Muresan, M. E., Bácskay, I., Kiss, R., Fehér, P. S., & Pallag, A. (2022) · Plants · doi:10.3390/plants11091244 · Cited by 179
SARS-CoV-2: characteristics and current advances in research
Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 168
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip
Guo, Y., Luo, R., Wang, Y., Deng, P., Song, T., Zhang, M., Wang, P., Zhang, X., Cui, K., Tao, T., et al. (2020) · 中国科学通报：英文版 · doi:10.1016/j.scib.2020.11.015 · Cited by 164
Neuropathobiology of COVID-19: The Role for Glia
Tremblay, M.-E., Madore, C., Bordeleau, M., Tian, L., & Verkhratsky, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592214 · Cited by 159
COVID-19: Complement, Coagulation, and Collateral Damage
Lo, M. W., Kemper, C., & Woodruff, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000644 · Cited by 160
How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms
Nikbakht, F., Mohammadkhanizadeh, A., & Mohammadi, E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102535 · Cited by 159
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Zhao, N., Di, B., & Xu, L. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.06.002 · Cited by 161
Severely low testosterone in males with COVID‐19: A case‐control study
Salonia, A., Pontillo, M., Capogrosso, P., Gregori, S., Tassara, M. G., Boeri, L., Carenzi, C., Abbate, C., Cignoli, D., Ferrara, A. M., et al. (2021) · Andrology · doi:10.1111/andr.12993 · Cited by 146
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 148
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
Ritter, A., Kreis, N., Louwen, F., & Yuan, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165793 · Cited by 145
Pincemail, J., Cavalier, E., Charlier, C., Cheramy‐Bien, J., Brevers, E., Courtois, A., Fadeur, M., Meziane, S., Goff, C. M. L., Misset, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10020257 · Cited by 144
Efforts at COVID-19 Vaccine Development: Challenges and Successes
Haque, A., & Pant, A. B. (2020) · Vaccines · doi:10.3390/vaccines8040739 · Cited by 141
2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
Ünal, M. A., Bayrakdar, F., Fusco, L., Beşbinar, Ö., Shuck, C. E., Yalçın, S., Erken, M. T., Özkul, A., Gürcan, C., Panatli, O., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101136 · Cited by 138
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Lee, W., Ahn, J. H., Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00292-7 · Cited by 141
Increased Plasma Heparanase Activity in COVID-19 Patients
Buijsers, B., Yanginlar, C., de Nooijer, A., Grondman, I., Maciej-Hulme, M. L., Jonkman, I., Janssen, N. A. F., Rother, N., de Graaf, M. J. J., Pickkers, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575047 · Cited by 133
Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 135
Self-citationDoes mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
Orvieto, R., Noach‐Hirsh, M., Segev-Zahav, A., Haas, J., Nahum, R., & Aizer, A. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00757-6 · Cited by 133
Neurological complications and infection mechanism of SARS-CoV-2
Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 140
Wei, Y., & Shah, R. (2020) · Pharmaceuticals · doi:10.3390/ph13070155 · Cited by 140
Aleebrahim‐Dehkordi, E., Molavi, B., Mokhtari, M., Deravi, N., Fathi, M., Fazel, T., Mohebalizadeh, M., Koochaki, P., Shobeiri, P., & Dehkordi, A. H. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101495 · Cited by 133
Impact of COVID-19 on Cardiovascular Disease
Vosko, I., Zirlik, A., & Bugger, H. (2023) · Viruses · doi:10.3390/v15020508 · Cited by 139
A case‐control study on the association between periodontitis and coronavirus disease (COVID‐19)
Anand, P. S., Jadhav, P., Kamath, K. P., Kumar, S. R., Vijayalaxmi, S., & Anil, S. (2022) · Journal of Periodontology · doi:10.1002/jper.21-0272 · Cited by 126
Castelli, V., Cimini, A., & Ferri, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02132 · Cited by 129
Vitamin D deficiency and co-morbidities in COVID-19 patients – A fatal relationship?
Biesalski, H. K. (2020) · NFS Journal · doi:10.1016/j.nfs.2020.06.001 · Cited by 130
Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
Haggag, Y. A., El‐Ashmawy, N. E., & Okasha, K. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109957 · Cited by 125
From causes of aging to death from COVID-19
Blagosklonny, M. V. (2020) · Aging · doi:10.18632/aging.103493 · Cited by 128
Morais, A. H. D. A., Aquino, J. D. S., da Silva-Maia, J. K., Vale, S. H. D. L., Maciel, B. L. L., & Passos, T. S. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003311 · Cited by 127
Late Complications of COVID-19; a Systematic Review of Current Evidence.
SeyedAlinaghi, S., Afsahi, A. M., MohsseniPour, M., Behnezhad, F., Salehi, M. A., Barzegary, A., Mirzapour, P., Mehraeen, E., & Dadras, O. (2021) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v9i1.1058 · Cited by 121
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, N., Chastain, W. H., Paz, M., Solch-Ottaiano, R. J., Murray-Brown, I. C., Befeler, J. B., Gressett, T. E., Longo, M. T., Engler-Chiurazzi, E. B., & Bix, G. J. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.02.002 · Cited by 123
Thyroid hormone concentrations in severely or critically ill patients with COVID-19
Gao, W., Guo, W., Guo, Y., Shi, M., Dong, G., Wang, G., Ge, Q., Zhu, J. H., & Zhou, X. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01460-w · Cited by 117
Small molecules in the treatment of COVID-19
Lei, S., Chen, X., Wu, J., Duan, X., & Men, K. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01249-8 · Cited by 119
Dissecting lipid metabolism alterations in SARS-CoV-2
Casari, I., Manfredi, M., Metharom, P., & Falasca, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101092 · Cited by 120
Coperchini, F., Chiovato, L., & Rotondi, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668507 · Cited by 116
Self-citationThye, A. Y.-K., Law, J. W., Tan, L. T., Pusparajah, P., Ser, H., Thurairajasingam, S., Letchumanan, V., & Lee, L. (2022) · Biology · doi:10.3390/biology11010061 · Cited by 122
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Yekedüz, E., Utkan, G., & Ürün, Y. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.028 · Cited by 114
Holmes, E. C., Wist, J., Masuda, R., Lodge, S., Nitschke, P., Kimhofer, T., Loo, R. L., Begum, S., Boughton, B. A., Yang, R., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00224 · Cited by 115
The Effect of Bacterial Infections, Probiotics and Zonulin on Intestinal Barrier Integrity
Serek, P., & Oleksy-Wawrzyniak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111359 · Cited by 120
Amor, S., Blanco, L. F., & Baker, D. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13523 · Cited by 114
Du, J., Liao, W., Liu, W., Deb, D. K., He, L., Hsu, P. J., Nguyen, T., Zhang, L., Bissonnette, M., He, C., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.023 · Cited by 113
Name, J. J., Souza, A. C. R., Vasconcelos, A. R., Prado, P. S., & Pereira, C. P. M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.606398 · Cited by 114
Targeting inflammation and cytokine storm in COVID-19
Huang, Q., Wu, X., Zheng, X., Luo, S., Xu, S., & Weng, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105051 · Cited by 111
Bearse, M., Hung, Y. P., Krauson, A. J., Bonanno, L., Boyraz, B., Harris, C. K., Helland, T. L., Hilburn, C. F., Hutchison, B. M., Jobbagy, S., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00790-1 · Cited by 117
Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
Agbuduwe, C., & Basu, S. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13491 · Cited by 112
Root-Bernstein, R. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042108 · Cited by 112
SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
Deinhardt‐Emmer, S., Böttcher, S., Häring, C., Giebeler, L. N., Henke, A., Zell, R., Jungwirth, J., Jordan, P. M., Werz, O., Hornung, F., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00110-21 · Cited by 114
Probiotics: A potential immunomodulator in COVID-19 infection management
Singh, K., & Rao, A. (2021) · Nutrition Research · doi:10.1016/j.nutres.2020.12.014 · Cited by 109
Udomsinprasert, W., Jittikoon, J., Sangroongruangsri, S., & Chaikledkaew, U. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00899-z · Cited by 108
SARS‐CoV‐2‐specific virulence factors in COVID‐19
Kumar, A., Prasoon, P., Kumari, C., Pareek, V., Faiq, M. A., Narayan, R. K., Kulandhasamy, M., & Kant, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26615 · Cited by 112
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
Lokhande, A. S., & Devarajan, P. V. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173748 · Cited by 109
Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study
Huang, D., Lin, S., He, J., Wang, Q., & Zhan, Y. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28008 · Cited by 108
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Słomka, A., Kowalewski, M., & Żekanowska, E. (2020) · Pathogens · doi:10.3390/pathogens9060493 · Cited by 106
COVID-19, cytokines, inflammation, and spices: How are they related?
Kunnumakkara, A. B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K. K., Dutta, U., Garodia, P., Gupta, S. C., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119201 · Cited by 107
Magnesium in Infectious Diseases in Older People
Dominguez, L. J., Veronese, N., Guerrero‐Romero, F., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13010180 · Cited by 105
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
Khatiwada, S., & Subedi, A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100073 · Cited by 105
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102
Zhao, H., Zhu, Q., Zhang, C., Li, J., Wei, M., Qin, Y., Chen, G., Wang, K., Yu, J., Wu, Z., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110825 · Cited by 101
Metadata
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
